| Literature DB >> 36200004 |
Jung-Lung Hsu1,2,3,4, Pei-Shin Gu5, Eugene Yu-Chuan Kang6,7, Chi-Chun Lai8, Fu-Sung Lo5.
Abstract
Background: Several factors could affect the cognitive dysfunction in patients with type 1 diabetes (T1D).Entities:
Mesh:
Substances:
Year: 2022 PMID: 36200004 PMCID: PMC9529476 DOI: 10.1155/2022/9082177
Source DB: PubMed Journal: J Diabetes Res Impact factor: 4.061
Demographic, clinical, and ophthalmic variables between different groups of age at onset in patients with T1D in this study.
| Variable | Age at onset ≤ 5 years old ( | Age at onset > 5 years old ( |
|
|---|---|---|---|
| Age (year) | 22.2 (19.7-25.5) | 26.1 (23.5-29.3) | <0.01 |
| Gender (M:F) | 18 : 11 | 32 : 46 | 0.05 |
| Age at onset (year) | 2.3 (1.4-3.7) | 9.4 (6.8-12.7) | <0.01 |
| Disease duration (year) | 20 (17-23) | 15.9 (13.3-19.2) | <0.01 |
| Education (year) | 16 (12-16) | 16 (12-16) | 0.02 |
| BMI (kg/m2) | 22.5 (19.4-26.0) | 22.5 (20.5-26.4) | 0.66 |
| HbA1c_5 (%) | 8.1 (7.4-9.3) | 7.8 (6.9-8.6) | 0.07 |
| HbA1c_10 (%) | 8.5 (7.3-9.7) | 8.2 (7.2-9) | 0.15 |
| Creatine (mg/dL) | 0.63 (0.52-0.79) | 0.66 (0.58-0.84) | 0.27 |
| HS_CRP (mg/L) | 0.63 (0.26-1.67) | 0.74 (0.36-1.94) | 0.55 |
| Homocysteine ( | 9 (7.0-10.4) | 8.6 (7.1-10.5) | 0.53 |
| LogMAR VA_OD | 0 (0-0.09) | 0 (0-0.05) | 0.28 |
| LogMAR VA_OS | 0 (0-0) | 0 (0-0) | 0.83 |
| AXL_OD (mm) | 24.7 (23.7-25.6) | 24.7 (23.6-25.7) | 0.85 |
| AXL_OS (mm) | 24.7 (23.9-25.5) | 24.7 (23.6-25.6) | 0.85 |
| CRT_OD ( | 266.5 (256-278) | 265 (255-282) | 0.95 |
| CRT_OS ( | 263 (256.5-282.5) | 266 (255-278.7) | 0.97 |
| Severity of diabetic retinopathy_OD | 0.83 | ||
| 0 | 21 | 63 | |
| 1 | 5 | 9 | |
| 2 | 2 | 4 | |
| 3 | 1 | 2 | |
| Severity of diabetic retinopathy_OS | 0.99 | ||
| 0 | 21 | 58 | |
| 1 | 5 | 13 | |
| 2 | 2 | 5 | |
| 3 | 1 | 2 |
IQR: interquartile range; BMI: body mass index; HbA1c: glycated hemoglobin; HS_CRP: high-sensitive C-reactive protein; LogMAR VA: logarithm of the minimum angle of resolution visual acuity; AXL: axial length; CRT: central retinal thickness; OD: oculus dexter; OS: oculus sinister.
Medication usage between different groups of age at onset in patients with T1D.
| Variable | Age at onset ≤ 5 years old ( | Age at onset > 5 years old ( |
|
|---|---|---|---|
| Insulin regimen | |||
| 1 | 23 (79.3%) | 53 (68.0%) | |
| 2 | 1 (3.4%) | 12 (15.3%) | |
| 3 | 1 (3.4%) | 12 (15.3%) | |
| 4 | 4 (13.8%) | 1 (1.3%) | |
| Total daily dose (U/kg/day) | 1.21 (0.98-1.36) | 1.09 (0.89-1.31) | 0.14 |
1: multiple-dose regimen with rapid and basal long-acting insulin. 2: premixed, short-acting insulin analogs given two to three times a day. 3: insulin pump. 4: regular and NPH given twice a day. IQR: interquartile range.
Comparison of clinical and ophthalmic variables between patients with and without diabetic retinopathy in T1D.
| Variable | Diabetic retinopathy group ( | No diabetic retinopathy group ( |
|
|---|---|---|---|
| Age (year) | 26.4 (23.3-29.4) | 24.5 (21.7-27.7) | 0.08 |
| Gender (M:F) | 6 : 12 | 39 : 40 | 0.22 |
| Age at onset (year) | 8.3 (4.4-11.8) | 7.2 (4.2-11.6) | 0.65 |
| Disease duration (year) | 17.8 (15.7-25.7) | 16.7 (13.3-20) | 0.12 |
| Education year (year) | 16 (16-16) | 16 (12-16) | 0.12 |
| BMI (kg/m2) | 24.8 (20.3-26.8) | 22.4 (19.9-25.9) | 0.38 |
| HbA1c_5 (%) | 8.7 (7.8-10) | 7.6 (6.9-8.2) | <0.01 |
| HbA1c_10 (%) | 9.1 (8.2-10.4) | 7.9 (7.1-8.7) | <0.01 |
| Creatine (mg/dL) | 0.63 (0.52-0.71) | 0.69 (0.58-0.83) | 0.03 |
| HS_CRP (mg/L) | 1.28 (0.42-2.3) | 0.61 (0.27-1.54) | 0.03 |
| Homocysteine ( | 8.4 (6.8-10) | 8.8 (7.3-10.7) | 0.23 |
| LogMAR VA_OD | 0 (0-0.09) | 0 (0-0) | <0.01 |
| LogMAR VA_OS | 0 (0-0.15) | 0 (0-0) | <0.01 |
| AXL_OD (mm) | 23.9 (22.9-25.1) | 24.9 (23.9-25.8) | <0.01 |
| AXL_OS (mm) | 24.0 (22.9-24.9) | 24.8 (23.9-25.8) | <0.01 |
| CRT_OD ( | 260 (247-278) | 267 (256-282) | 0.12 |
| CRT_OS ( | 263 (254-281) | 266 (255-279) | 0.70 |
BMI: body mass index; HbA1c: glycated hemoglobin; HS_CRP: high-sensitive C-reactive protein; LogMAR VA: logarithm of the minimum angle of resolution visual acuity; AXL: axial length; CRT: central retinal thickness; OD: oculus dexter; OS: oculus sinister.
Spearman's correlation coefficients between CANTAB tests and clinical and ophthalmic variables.
| Row | MOT (MOTML) | OTS (OTSPSFC) | PAL (PALTEA28) | RTI (RTISMDRT) | RVP (RVPML) | SWM (SWMBE4) | MTS (MTSRCAMD) | Disease duration | HbA1c_5 | avgAXL | avgCRT |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ERT (ERTRT) | 0.15 | -0.03 | 0.19∗ | 0.03 | 0.06 | -0.01 | 0.32∗∗ | 0.16 | 0.14 | -0.09 | -0.15 |
| MOT (MOTML) | -0.06 | 0.25∗∗ | -0.03 | -0.32∗∗ | 0.27∗∗ | 0.21∗ | 0.00 | 0.13 | 0.07 | -0.15 | |
| OTS (OTSPSFC) | -0.14 | -0.14 | -0.08 | -0.34∗∗ | 0.02 | 0.02 | 0.05 | -0.02 | 0.00 | ||
| PAL (PALTEA28) | 0.02 | -0.09 | 0.11 | 0.22∗ | 0.06 | 0.06 | -0.04 | -0.02 | |||
| RTI (RTISMDRT) | 0.33∗∗ | -0.02 | 0.22∗ | 0.15 | -0.00 | 0.00 | -0.27∗∗ | ||||
| RVP (RVPML) | -0.07 | 0.09 | 0.06 | -0.22∗ | -0.06 | -0.07 | |||||
| SWM (SWMBE4) | 0.02 | 0.17 | -0.15 | -0.13 | -0.16 | ||||||
| MTS (MTSRCAMD) | 0.17 | -0.01 | -0.12 | -0.26∗∗ | |||||||
| Disease duration | 0.10 | -0.20∗ | -0.19 | ||||||||
| HbA1c_5 | -0.15 | -0.13 | |||||||||
| avgAXL | 0.21 |
ERT: emotion recognition task; MOT: motor screening task; OTS: one touch stockings of Cambridge; PAL: paired associates learning; RTI: reaction time task; RVP: rapid visual information processing; SWM: spatial working memory; MTS: match to sample visual search; HbA1c_5: average values of glycated hemoglobin 5 years before the current study; avgAXL: average values of axial length; avgCRT: average values of central retinal thickness. Item in parenthesis represents the key parameter in its CANTAB test.
Figure 1Regression analyses showed the significantly negative correlations between the average values of CRT and (a) mean latency of RVP test and (b) mean time to correct MTS test.